glp-1 microdosing for menopause GLP 1 and the Long Term Benefits Women: Shamsah Amersi, MD: OB-GYNs Micro Dosing GLP-1 After 50...?

This review aims to evaluate the existing evidence on the prognostic role of obesity in BC patients and assess current data regarding the efficacy and safety of GLP-1 receptor agonists (GLP-1 RAs) in women with overweight or obesity with BC

There is no benefit to weight loss during pregnancy and it may cause harm to the unborn baby

Tay KP and Lim PH: Corporeal plication for correction of penile curvature

BPC-157 isnt approved for fertility treatment by leading agencies and its still considered experimental, which significantly impacts study design, funding, and ethical oversight for human trials

Real-world adherence and discontinuation of glucagon-like peptide-1 receptor agonists therapy in type 2 diabetes mellitus patients in the United States